More information is available on the use of HMDP in the ASNC and EANM Cardiac Amyloidosis Practice Points
The purpose of this document is to identify the critical components involved in performing 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) or 99mTechnetium-hydroxymethylene diphosphonate (99mTc-HMDP) imaging for the evaluation of cardiac transthyretin amyloidosis (ATTR).
Resource Type
Practice Points
Clinical Topic
Cardiac Amyloidosis
Year Published
2019
Related Resources
ASNC Quality Metrics for Cardiac Amyloid Radionuclide Imaging – 2024
ASNC released a new document defining quality standards for cardiac amyloid radionuclide…
For Patients - Year Published: 2022
Think Amyloid Patient Pocket Guide
Download now and share with your patients!
Posters - Year Published: 2021
Think Amyloid Echocardiography Laboratory Poster
Download now to display in your lab!
